Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer. Cancer. 2006 Jun 01; 106(11):2459-65.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Humans
Ketoconazole
Male
Middle Aged
Mitoxantrone
Neoplasms, Hormone-Dependent
Prostate-Specific Antigen
Prostatic Neoplasms
Survival Rate
Treatment Outcome
authors with profiles
Mark Kozloff